Latest article
Poxel Presents New Outcomes of Imeglimin Part 2 and three Scientific Research in Japan...
Lyon, France - (BUSINESS WIRE) - POXEL SA (Euronext - POXEL - FR0012432516), a biopharmaceutical company...
preserve health plan over festive interval
There are many decisions to be made in December. I'm not just talking about deciding what to buy mom or dad: you need...